Download full-text PDF

Source
http://dx.doi.org/10.1016/0024-3205(79)90289-3DOI Listing

Publication Analysis

Top Keywords

nucleolar immunofluorescence
4
immunofluorescence human
4
human hematological
4
hematological malignancies
4
nucleolar
1
human
1
hematological
1
malignancies
1

Similar Publications

Hydroxysafflor yellow A attenuates the inflammatory response in cerebral ischemia-reperfusion injured mice by regulating microglia polarization per SIRT1-mediated HMGB1/NF-κB signaling pathway.

Int Immunopharmacol

February 2025

Department of Pharmacy, Anhui University of Chinese Medicine, Hefei, China; Anhui Province Key Laboratory of Traditional Chinese Medicine Decoction Pieces of New Manufacturing Technology, Bozhou 236000, China. Electronic address:

Background: Hydroxysafflor yellow A (HSYA), an active component isolated from Carthamus tinctorius L., has demonstrated potent protective effects against cerebral ischaemia/reperfusion (I/R) injury. Microglial polarisation plays a crucial role in I/R.

View Article and Find Full Text PDF

Association between antinuclear antibodies and pregnancy prognosis in recurrent pregnancy loss patients.

Hum Reprod

December 2024

Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Aichi, Japan.

Study Question: Can antinuclear antibodies (ANA) affect the subsequent live birth rate (LBR) in patients with unexplained recurrent pregnancy loss (RPL) in the absence of antiphospholipid antibodies (aPL)?

Summary Answer: Women with unexplained RPL have a high probability of live birth following a positive pregnancy test (>70%), being similar between those with positive and negative ANA testing, regardless of the cut-off value.

What Is Known Already: The RPL guidelines of the ESHRE state that 'ANA testing can be considered for explanatory purposes'. However, there have been a limited number of studies on this issue and sample sizes have been small, and the impact of ANA on the pregnancy prognosis is unclear.

View Article and Find Full Text PDF

Vitexin mitigates oxidative stress, mitochondrial damage, pyroptosis and regulates small nucleolar RNA host gene 1/DNA methyltransferase 1/microRNA-495 axis in sepsis-associated acute lung injury.

Inflammopharmacology

December 2024

Translational Research Lab, Srinivas Ramanujan Block, Department of Biotechnology, Faculty of Life Sciences, Jamia Millia Islamia, New Delhi, 110025, India.

Article Synopsis
  • - This study investigated how vitexin impacts sepsis-related acute lung injury, utilizing network pharmacology and various lab experiments to assess its potential in preventing cell death and regulating specific genetic pathways.
  • - The researchers created a model of acute lung injury in mice and human lung cells, discovering that vitexin effectively reduced inflammation and lung damage while enhancing cell recovery and function through multiple experimental techniques.
  • - Results revealed that vitexin lowers oxidative stress and influences epigenetic factors related to inflammation, highlighting its potential as a treatment for acute lung injury and suggesting new therapeutic targets for future research.
View Article and Find Full Text PDF

Cellular differentiation requires highly coordinate action of all three transcriptional systems to produce rRNAs, mRNAs, and various "short" and "long" non-coding RNAs by RNA Polymerase I, II, and III systems, respectively. The RNA Polymerase I catalyzes transcription of about 400 copies of rDNA genes generating 18S, 5.8S, and 28S rRNA molecules from the individual primary transcript.

View Article and Find Full Text PDF

Background: Aberrant accumulation of R-loops leads to DNA damage, genome instability and even cell death. Therefore, the timely removal of harmful R-loops is essential for the maintenance of genome integrity. Nucleolar R-loops occupy up to 50% of cellular R-loops due to the frequent activation of Pol I transcription.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!